Using Registers to Study Effectiveness and Safety of Drugs

Cover Page

Cite item

Full Text

Abstract

The article discusses the main aspects of registers use to evaluate the effectiveness and safety of drugs. It is noted that the results of the randomized clinical trials are currently constitute the highest level of evidence in medicine, but they have several limitations. Besides, in many
cases evidence based on the results of the randomized clinical trials (RCTs) is simply missing. In this connection need for observational studies that, despite some limitations often supplement the information obtained in the RCT is discussed. Registers as the way to study the effectiveness and safety of drugs could help overcome some limitations of observational studies. The examples of both Russian and foreign studies held within registers in order to study the effectiveness of drugs in cardiology are provided. The framework for RCTs and registries contribution in studying effectiveness and safety of a drug is proposed.

About the authors

L. Yu. Drozdova

National Research Center for Preventive Medicine

Russian National Society of Evidence-Based Pharmacotherapy

Author for correspondence.
Russian Federation

N. P. Kutishenko

National Research Center for Preventive Medicine

Russian National Society of Evidence-Based Pharmacotherapy

Russian Federation

M. L. Ginzburg

National Research Center for Preventive Medicine

Russian National Society of Evidence-Based Pharmacotherapy

Lyuberetsy district hospital No.2

Russian Federation

References

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c)



СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 36931 от  21.07.2009.